How Champions Oncology Inc (CSBR) Stacks Up Against Its Peers

As aggregate interest increased, key hedge funds have jumped into Champions Oncology Inc (NASDAQ:CSBR) headfirst. GRT Capital Partners, led by Gregory Fraser, Rudolph Kluiber, and Timothy Krochuk, established the most outsized position in Champions Oncology Inc (NASDAQ:CSBR). GRT Capital Partners had $0 million invested in the company at the end of the quarter. Millennium Management, one of the 10 largest hedge funds in the world also initiated a big position during the quarter. The only other fund with a brand new CSBR position is Ken Griffin’s Citadel Investment Group.

Let’s now take a look at hedge fund activity in other stocks similar to Champions Oncology Inc (NASDAQ:CSBR). These stocks are Violin Memory Inc (NYSE:VMEM), Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Cinedigm Digital Cinema Corp (NASDAQ:CIDM), and Dextera Surgical Inc (NASDAQ:DXTR). This group of stocks’ market caps are closest to CSBR’s market cap.

As you can see these stocks had an average of 5 hedge funds with bullish positions and the average amount invested in these stocks was $2 million. That figure was $2 million in CSBR’s case. Violin Memory Inc (NYSE:VMEM) is the most popular stock in this table. On the other hand Cinedigm Digital Cinema Corp (NASDAQ:CIDM) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks Champions Oncology Inc (NASDAQ:CSBR) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None